INTRODUCTION
The recent FDA approval for the marketing of eteplirsen, a phosphoromorpholidate antisense oligonucleotide (ASO) (1, 2) , for the treatment of Duchenne's muscular dystrophy, has propelled the clinical development of splice-switching oligonucleotides (SSOs) (3) . At the same time, drisapersen, a phosphorothioate (PS) SSO, which like eteplirsen was designed to produce exon skipping in the dystrophin mRNA, did not fare as well, missing its primary endpoint (the 6-min walking test). Though the use of SSOs as therapeutic molecules is promising and has shown to be well tolerated, including after multiple intrathecal administrations as in the case of nusinersen (4), their potential, as for any therapeutic antisense ON, is hampered by substandard delivery to their targeted cells. Attempts to improve efficacy by escalating ON doses frequently leads to unacceptable toxicity. Chemical modifications, such as locked nucleic acid (LNA) have proven to increase ON efficacy in vivo, but the required concentrations for some therapeutic applications, depending on the ON sequence, may also produce toxicity (5, 6) .
The LNA modification was first synthesized approximately 20 years ago (7, 8) . PS ONs containing LNA moieties are not only highly resistant to nucleases, but each LNA can increase the T m of an RNA/PS LNA ON duplex by up to [2] [3] [4] [5] [6] • C per residue (8, 9) . PS LNA ONs are active SSOs, having been shown to induce exon skipping in vivo as well as in vitro, especially in the colon, small intestine and liver (10) . However, for therapeutic applications it is critically important to develop strategies that take advantage of these characteristics at low ON doses so that the potential for off target effects are reduced.
The PS LNA SSO employed in this work (SSO-654) is a 16mer. The LNA moieties are interspersed in the ON chain. As mentioned above, this substitution promotes nuclease stability and increases the stability of the ON hybrid with the nuclear pre-mRNA. At the same time, LNA substitution blocks the induction of RNAse H activity, which would cleave the pre-mRNA and terminate exon skipping. To monitor ON efficacy, we employed a splice-switching model in which HeLa cells have been engineered to express the enhanced green fluorescent protein (EGFP; HeLa EGFP-654) (11, 12) . In this model, a mutated ␤-globin intron, which creates a new 5 splice site and activates an upstream cryptic 3 splice site, has been inserted into the EGFP coding sequence to generate an additional exon. This exon prevents canonical splicing and EGFP translation. Treatment of these cells with a SSO targeted to the introduced 5 splice sites causes exon skipping and the reconstitution of the EGFP correct reading frame (12) .
Several years ago, we (13, 14) discovered the general principle that PS LNA ONs and other highly stabilized ONs such as 2 F-arabinose nucleic acids (15) can enter cells in the absence of any transfection vehicles and can also silence gene expression. This process is called gymnosis from the Greek word for naked, and is different from the process of 'free uptake' which only refers to the absence of transfection reagents (16) , and has never been associated with silencing of gene expression. The process of gymnosis in tissue culture more resembles in vivo ON uptake in saline formulations than does the process of transfection (13) , and is often used for both ASO and SSO experiments.
The concentrations of ON in the media for an optimal gymnosis experiment are often in the 250 nM-5 M range. However, while gymnotic delivery of ONs generally results in excellent ON function, it still can be associated with inherent potential toxicity and with sub-optimal in vivo delivery. Thus, our strategy aims to improve the activity of PS LNA ONs (referred from this point on as ONs) after gymnosis in order to improve the concentration dependence of ON function. Ideally, such a strategy would employ small molecules that are distributed widely, are inexpensive and non-toxic at the concentrations employed.
However, there are few such small molecules to hand. In 2013, a small molecule known as Retro-1, which reduces the toxicity of plant and bacterial compounds (17) emerged from a high throughput screen. Retro-1 enhanced both SSO and ASO efficacy when the ONs were delivered by gymnosis. However, the optimal concentration of Retro-1 was ∼50-100 M, and the compound is also poorly watersoluble. (In a subsequent high throughput screen of >100 000 compounds, a series of 3-deazapteridine analogues were discovered (18) that at a concentration of 10 M substantially increased SSO activity.) Dantrolene (25-50 M), a drug used clinically in the treatment of malignant hyperthermia, and other small molecules that target the ryanodine receptor have been demonstrated to promote SSO modulated exon skipping in myotubes in vitro and in mdx mice (19) .
In this work, we elected to study the effects of ammonium ion (NH 4 + ) on the activity of ONs because of our previous results (20) , which highlighted the importance of endosomal maturation for ON activity and because it has previously been shown that NH 4 + affects the maturation and outcomes of late endosomes (21) (22) (23) .
Here, we demonstrate that NH 4 + can facilitate SSO activity in the HeLa EGFP-654 model in vitro, in the absence of, or with very limited, toxicity. NH 4 + also improves in vitro ASO activity both in attached and suspension cells, including in Jurkat T and CEM T cells, where gene silencing has historically been difficult. Finally, we demonstrate that NH 4 + can interact synergistically with arsenic trioxide (As III, arsenite in solution) to significantly promote ON function in cells.
MATERIALS AND METHODS

Cell culture
HeLa EGFP-654, HCT 116 and SW480 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) and 2 mM L-glutamine. LNCaP cells and the Jurkat T and CEM T lymphocyte cell lines were maintained in RPMI 1640 medium supplemented with 10% FBS and 2 mM L-glutamine. Cultures of all cell lines were maintained at 37
• C in a humidified 5% CO 2 incubator.
Reagents and antibodies
Ammonium chloride (NH 4 Cl), arsenic trioxide (As 2 O 3 ) and oleic acid (OA) were purchased from Sigma-Aldrich (Milwaukee, WI, USA); Ambroxol hydrochloride (Amb) and cyclohexylamine were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). An arsenite solution was prepared by dissolving As 2 O 3 in minimal volumes of 1 N sodium hydroxide (NaOH). The arsenite solution (referred to in the manuscript as As III) was then diluted with phosphate buffered saline to a concentration of 10 mM as a stock solution. For Amb and OA, the desired concentrations were obtained by dissolving Amb in DMSO and OA in ethanol. Other compound solutions were prepared as per the manufacturer's recommendations. The AR (N-20, used at a 1:1000 dilution) and GFP (sc-9996; also used at a 1:1000 dilution) antibodies were purchased from Santa Cruz Biotechnology. The ␤-catenin antibody (#4270; 1:1000) was purchased from Cell Signaling Technology (Danvers, MA, USA) and the anti-␣-tubulin antibody (1:3000) from Sigma-Aldrich; the anti-BCL2 antibody (clone 124; 1:500) was from Dako (Santa Clara, CA, USA).
Antisense oligonucleotides
The sequences of ONs used in this work are listed in Table  1 . All are phosphorothioates, with DNA given in lower case letters and LNA modifications in upper case letters. 'm' = 5-methylcytosine. ONs were delivered by gymnosis by directly adding them into the culture media (14) .
Western blot
Cells were harvested by trypsin digestion and washed once with PBS. Cell pellets were lysed in cold RIPA buffer containing protease inhibitors. Cellular RIPA lysates were sonicated for 2 s and then rested on ice for 5 min. Cell debris was removed by centrifugation at 12 000 × g for 10 min at 4
• C. Protein concentrations were determined using the Pierce ® BCA Protein Assay kit (Thermo Fisher Scientific, Waltham, MA, USA). Aliquots of cell extracts containing 30-40 g of protein were resolved by SDS-PAGE gel electrophoresis, and then transferred to PVDF membranes. After treatment with the appropriate primary and secondary antibodies, enhanced chemiluminescence was performed. Protein signals on the blot were quantified with the ImageJ program and protein expression was normalized to control = 100%. • C × 30 s for 40 cycles followed by a melting curve analysis. The AR mRNA levels were normalized to the expression of ␤-actin mRNA, which served as the internal control.
Flow cytometry
Cells were trypsinized, collected by centrifugation at 800 × g for 5 min and re-suspended in PBS or culture media for flow cytometric analyses. Flow cytometry data (a minimum of 10,000 events) were collected by a CyAn Flow Cytometer (Beckman Coulter, Brea, CA, USA), and were analyzed by the FlowJo program (Tree Star, Inc., Ashland, OR, USA) to determine fluorescence intensity versus cell number. Cell apoptosis assays were performed with the Annexin V-FITC Apoptosis Detection kit (Abcam, Cambridge, UK) following the manufacturer's recommendations. In brief, 5 × 10 5 cells were collected by centrifuging at 800 × g for 5 min and re-suspended in 500 l of binding buffer. Annexin V-FITC and propidium iodide (PI) were added to the cell suspensions, which were incubated at room temperature for 5 min prior to the flow cytometric assays. For the viability assays, cells were harvested, re-suspended in PBS containing 1 g/ml DAPI (Molecular Probes, Eugene, OR, USA) and incubated for 5 min prior to the flow cytometric experiments. 4 per well) were seeded into 48-well plates overnight and treated the following day as indicated in the text and figure legend. Cells were fixed by adding an equal volume of cold 10% trichloroacetic acid solution to the culture media. The tissue culture plates were then placed at 4
Cell growth assays
• C overnight. The following day, cells were washed three additional times with Millipore water, air-dried overnight and stained with 0.06% SRB for 30 min at room temperature in the dark. Cell-bound SRB was then solubilized in 10 mM Tris buffer (pH 10) and its absorbance determined at 510 nm by a microplate reader.
Statistical analysis
Quantifying the interaction between the ON and ammonium and As III treatments was performed by a combination index (CI) plot using the Chou-Talalay method (24) . The significance of the data was calculated by determining the mean ± standard deviation (S.D.). One way ANOVA was performed to determine and compare the means for the samples analyzed in each experiment. For the experiments performed to asses ON efficacy, the adjusted P-values were obtained by employing a post-hoc Dunnett's test to compare each treatment group to a single control. The Dunnett's test was selected to avoid overestimation of the ON efficacy differences among pairs (25) . However, so as not to underestimate toxicity by increasing the stringency of the statistical calculations with the Dunnett's test (25) , toxicity assays (e.g. Figure 2A and B, Supplementary Figure S7 ), were analyzed with a two-sample Student's t-test without the adjustment of multiple comparisons.
The statistical analyses were performed with the multcomp package in R software (http://www.r-progject.org/). Comparisons were considered to be significant when the adjusted or non-adjusted P-values were <0.05. All P-values are two-sided unless otherwise noted.
RESULTS
Ammonium ion enhances therapeutic SSO function in cells
The HeLa EGFP-654 cell line (11, 12) , stably expresses an EGFP pre-mRNA whose coding sequence is interrupted by the insertion of a mutated ␤-globin intron. The point mutation in this intron creates a new 5 splice site, which in turn allows for an upstream cryptic 3 splice site to be utilized. The result is in the inclusion of an intron fragment (now an exon) within the spliced EGFP mRNA. The newly introduced exon interrupts the correct EGFP reading frame and leads to lack of fluorescence. The binding of SSO-654 to the introduced 5 splice site within the ␤-globin intron causes the skipping of the internal exon and restores the correct EGFP reading frame and EGFP protein expression (Figure 1A) . We used this cell model to see if we could improve ON efficacy. We have demonstrated that ammonium chloride (NH 4 + ) significantly enhanced the function of a SSO (SSO-654, Figure 1B + (B) for 2 days. Cell growth and proliferation were assayed by SRB staining. The growth and proliferation of treated cells were normalized to non-treated controls as 100%, indicated in the graph by a value of 1 (100% cell growth after 48 hr of culture, SRB staining). The combination of NH 4 + and SSO-654 did not increase growth inhibition compared with NH 4 + alone (P = 0.45). For the toxicity experiments, the P-values were not adjusted to avoid the likelihood that the increased stringency of the statistical calculations could mask any differences in the treatment toxicity among the individual groups. Data are represented as the mean ± SD, n = 3. **P < 0. Figure 1D-F) .
Consistent with these results, other ammoniumcontaining compounds such as ammonium acetate and ammonium bicarbonate, as suspected, produced comparable effects on SSO-654-mediated EGFP expression (Supplementary Figure S1) . Taken together, these data demonstrated that NH 4 + , at a range of clinically relevant concentrations, significantly facilitated the ability of SSO-654 to promote EGFP expression in a dose-dependent manner in HeLa EGFP-654 cells.
Ammonium ion exposure does not affect HeLa EGFP-654 cell viability
NH 4
+ can be inhibitory to the growth of and toxic for mammalian cell cultures (26, 27) . Therefore, we examined whether the exposure NH 4 + combined with a SSO ON could affect the growth, proliferation, and viability of HeLa EGFP-654 cells. As shown in Figure 2A Figures S2 and S3 ).
Ammonium ion also facilitates ASO ability to silence gene expression in cancer cells
We then investigated whether NH 4 + could facilitate the activity of PS LNA gapmer ASOs (ASOs) when delivered to a variety of cells by gymnosis. LNCaP prostate cancer cells were treated with an ASO targeting either the androgen receptor (AR-ASO), or BCL-2 (BCL2-ASO) or ␤-catenin (␤-Cat-ASO) mRNAs, with or without added NH 4 + . As shown in Figure 3A , the presence of NH 4 + facilitated ASOinduced gene silencing in a target-specific manner. The combination of treatment with NH 4 + [5 mM] and the AR-ASO [1 M] for three days led to an 80% reduction in AR protein expression (lane 4 in Figure 3A) . Treatment with the AR-ASO alone resulted in only a 40% AR reduction (lane 3 in Figure 3A) . Furthermore, treatment with the identical concentrations of the BCL2-ASO and NH 4 + led to a nearly completely depletion of BCL-2 protein expression (98% BCL2-ASO and NH 4 + versus 70% with the BCL2-ASO alone; lane 6 versus lane 5 in Figure 3A) . Figure 3A) .
We then obtained a dose response for the AR-ASO in LNCaP cells and demonstrated that 0.25 M AR-ASO when combined with NH 4 + induced greater AR reduction than 1 M AR-ASO alone (lane 4 versus lane 2 in Figure  3B ). This result was confirmed by qRT-PCR analysis, which demonstrated that the NH 4 + and AR-ASO combination significantly reduced AR mRNA expression (by about 40%, adjusted P-value < 0.003), compared with the AR-ASO alone ( Figure 3C ). Furthermore, this outcome could be recapitulated in other cells lines: We confirmed that NH 4 + increased the efficacy of the ␤-Cat-ASO by ∼2-fold in SW480 colon cancer cell lines and nearly eliminated ␤-catenin gene expression in HCT 116 colon cancer cells (lane 4 versus lane 3 in Figure 3D and E). In no case did NH 4 + alone have any effect on the expression of those genes.
Ammonium ion facilitates ASO-directed gene silencing in transfection-resistant leukemia cells
We then examined whether NH 4 + could promote gymnosis in non-adherent leukemia cells. These cells are often resistant to liposome-based transfection, a delivery method widely employed for the manipulation of gene expression. We examined Jurkat cells, a T lymphocyte cell line, and confirmed that these cells were indeed resistant to gene silencing by Lipofectamine ® 3000-mediated-transfection of the BCL2-ASO ( Figure 4A and not shown). This resistance was found even at high ASO concentrations (50-100 nM; lane 2 and 3 in Figure 4A ). Some silencing of the BCL-2 protein 
Ammonium ion simultaneously facilitates gene targeting of two ONs in cells
We then investigated whether NH 4 + could simultaneously facilitate the silencing ability of two ONs in cells in culture. As shown in Figure 5A Figure 5A ). We then titrated the concentration of the SSO-654 (evaluated by Western blotting, Figure 5B ) or the BCL2-ASO (evaluated by flow cytometry, Figure 5C ) in the presence or absence of NH 4 + . As shown in Figure 5B , we found that high concentrations of the SSO-654 (5 M) could only partially reduce the BCL2-ASO-directed gene silencing (compare lane 9 with lane 3), while the SSO-654 at lower concentrations [1-2 M] fully maintained the activity of both (compare lane 5 and 7 with lane 3 in Figure 5B ). In contrast, when the concentration of SSO-654 was kept constant Figure S4) . Fi- nally, NH 4 + also simultaneously enhanced directed genesilencing by two gapmer ONs targeting the BCL-2 or the ␤-catenin expression delivered to HCT-116 cells (Figure 5D ).
At the highest concentrations of oligos + NH 4 + , there may be some suppression of SSO activity due to the presence of the BCL2 ON. The degree of suppression may also be affected by certain ON sequences and/or cell lines.
Ammonium ion facilitates ON function, possibly by affecting the endosomal pathway
To understand how NH 4 + facilitates ASO and SSO activity, we first examined whether it increased ON uptake in cells. As shown in Figure 6A , NH 4 + [5 mM] did not significantly affect the cellular uptake of a Cy5-labeled ASO (Cy5-ASO) in LNCaP cells (P = 0.98), suggesting that the activity of 
NH 4
+ occurs intracellularly. NH 4 + is known to inhibit endosomal maturation and lysosome fusion (21, 22, 28) . Our data are not inconsistent with the idea previously demonstrated that the ammonium ion inhibits the fusion of endosomes with lysosomes (21) . It is also possible that an NH 4 + -induced endosomal swelling could contribute to the egress of ONs. However, other mechanisms may be involved, and without additional data, no conclusions can be drawn.
As noted above, endosomal maturation plays a critical role in ON delivery within cells after PS ON uptake via adsorptive and/or fluid phase endocytosis, as it has been found that 50% of the internalized ON is associated with lysosomes and other vesicular structures (29) . Two other inhibitors of endosomal maturation/fusion, Ambroxol (Amb), and cyclohexylamine (CHA) (Supplementary Figure S5 ) in addition to OA (Supplementary Figure  S5) , which stimulates endosomal maturation, also significantly facilitated the ability of SSO-654 to promote EGFP expression in HeLa EGFP-654 cells when delivered by gymnosis ( Figure 6B , all with adjusted P-values <0.01, and Supplementary Figure S6A and B, all with adjusted P-values < 0.001), indicating that enhancement of ON efficacy can occur at the level of the endosome. It is noteworthy that the latter compounds are organic amines; however, their pKas [8.25 (30) By western blotting, cells treated with NH 4 + + As III manifested more than a ten-fold increase in SSO-654-mediated EGFP expression than treatment with the SSO-654 alone. This is compared to a 3-to 5-fold upregulation of SSO-654-mediated EGFP expression by either NH 4 + or As III as single agents. This was evaluated by western blotting ( Figure 7B ) and by flow cytometry (Figure 7C and D) . To investigate whether these two small molecules in combination produced a synergistic effect on SSO activity, we performed a dose-response study (see Supplementary Table  S1 ). Quantitative analysis was performed by flow cytometry, which allowed us to produce a combination index (CI) plot using the Chou-Talalay method (24) , in which the line parallel to the x-axis (CI = 1, Figure 7E ) represents the divide between synergism (CI = 1) and antagonism (CI >1) for the two drugs being analyzed in combination. A CI < 1 demonstrates drug synergism, which increases as CI decreases. The two most relevant points in our experiment, performed at fractional activity (Fa), = 0.5 and 1.0, fall well below CI = 1 (Figure 7e ; note that the lower ammonium + As III concentrations produced essentially only basal SSO-654 activity). Therefore, the combination of NH 4 + and As III was synergistic with respect to the facilitation of SSO-654 function in HeLa EGFP-654 cells. (21, 22, 28) , these EEs matures into the late endosomes/multivescicular bodies (LEs/MVBs), which will fuse with nuclease-rich lysosomes where ONs are sequestered/degraded. NH 4 + inhibits endosomal acidification, causes endosomal swelling, and inhibits fusion of LEs with lysosomes. Prolonging maturation of the endosomes in addition to inhibiting fusion between later endosomes and lysosomes may facilitate ON escape from endosomes into the cytosol. As III, which does not appear to affect the release of ONs from the endosomal compartment, facilitates the entry of cytoplasmic ON into the nuclear compartment via inducing a cellular stress response (Castanotto et al., submitted) . The combination of NH 4 + and As III is synergistic with respect to the nuclear function of SSO-654, perhaps via these proposed mechanisms.
DISCUSSION
In this work, we elected to study the effects of NH 4 + on the activity of ONs because of our previous results (20) , which highlighted the importance of endosomal maturation for ON activity and because it has previously been shown that NH 4 + affects the maturation and outcomes of late endosomes (21) (22) (23) . After cell surface adsorption, or through fluid phase endocytosis, ONs become localized inside the cell in early endosomes. The maturation of early to late endosomes (LEs)/multivesicular bodies (MVBs) is at least in part under the control of PKC-␣. Blocking PKC-␣ expression by a variety of methods leads to a marked diminution of ASO gene silencing, suggesting that ONs, at least in part, exit the endosomal pathway at the level of the LE/MVBs. In this context, it is of interest that Ago-2, one of the proteins that interacts with ONs (32) and shuttles the ONs to the cell nucleus (Castanotto et al., submitted), can physically interact with the LE (33) . (However, it still remains unclear how negatively charged PS ONs, when delivered by gymnosis, can penetrate the hydrophobic late endosomal membrane.)
LEs/MVBs can also fuse with lysosomes; we and others (32, 34) have demonstrated SSO accumulation in lysosomes, a process deemed to be non-productive with respect to ON activity. The ability of NH 4 + to block/slow the fusion of LEs/MLVs with lysosomes (21-23) might allow the endosomal cargo to be retained for longer times in the LE/MVB, increasing its ability to exit the endosomal pathway. The exit of ONs from the endosome might also be aided by the ability of NH 4 + and of other lysosomotropic weak bases, to also cause endosomal swelling (35, 36) . The way that endosomal swelling is produced by NH 4 + is complex, but cannot be due to proton sponge effects, as the pK a of NH 4 + = 9.26 (31) , two orders of magnitude higher than the intracellular pH. The endosomal swelling effects of NH 4 + may mimic those of the so-called cell penetrating peptide-ONs, in which the peptide moieties are usually short (9-30 amino acids) polypeptides that are often replete with arginines and lysines (37) , both of which are organic amines.
However, the mechanism of action of NH 4 + , regardless of how it enhances ONs (ASO and SSO) function, appears to be different than that of As III (a mechanistic model is suggested in Figure 8 ). The latter enhances ON function in the nucleus but not in the cytoplasm (Supplementary Figure S8) , while NH 4 + enhances function in both cellular compartments, possibly by increasing the total amount of ON released into the cytoplasm. This is in accord with our previous observations that As III, through induction of cellular stress, facilitates shuttling of ONs from the cytoplasm to the nucleus (Castanotto et al., submitted) . In contrast to As III, under the conditions of our experiments, NH 4 + [5 mM], does not appear to induce a cellular stress response and thus the formation of a ONs-binding stressinduced response complex (SIRC), which consists of Ago-2, nucleolin, and Yb-1, in addition to other proteins (Castanotto et al., submitted). Furthermore, the data demonstrating (Figure 7 ) that the higher concentrations of NH 4 + /As III are synergistic, as defined by the combination index (CI) method of Chou and Talalay (24) , also suggest that these small molecules augment ON activity by different mechanisms. Of note, we performed a gene expression profiling study with Jurkat T cells under our experimental conditions. We found that NH 4 + treatment did not detectably affect the expression of known genes involved in the endocytosis or in the endosome/lysosome pathway (not shown). This finding is consistent with our model that NH 4 + regulates the biogenesis and maturation of endosome/lysosome at the biochemical level. The only detectable changes in gene expression clustered with those involved in lipid biosynthesis and metabolic pathways (not shown), which is consistent with previously published gene expression profiles following NH 4 + treatment (38) . The possibility that the positively charged NH 4 + augments binding of a ON to its mRNA target by charge masking may be discounted, as experiments examining the T m of DNA/RNA duplexes in the presence or absence of 5 mM NH 4 + demonstrated no difference (not shown).
In summary, the combination of As III, which has previously been shown to be a potential anti-leukemia drug (39) (40) (41) (42) , and/or NH 4 + (or other organic amines such as Amb.,or other molecules such as OA that act on the endosomal maturation pathway), is an easy, inexpensive, nontoxic and effective way to improve SSO and ASO activity after their delivery by gymnosis, even in non-attached, difficult to transfect cells. Ca 2+ has been shown to improve ON function by increasing its cellular uptake (43) . However, the toxicity of Ca 2+ , which at the required 9 mM concentration is not clinically viable, makes the As III/NH 4 + combination more appealing. Like As III, NH 4 + , which possesses expectorant and diuretic properties, is an FDA-approved drug that has been used for the treatment of human diseases. Most likely, the synergistic increase in function is produced because these agents, as demonstrated by the Combination Index plot, appear to be active by different mechanisms: NH 4 + could possibly be acting at the level of the endosomes (as suggested in Figure 8 ), while As III seems to induce a cellular stress reaction that promotes cytoplasmic-nuclear ON shuttling (Castanotto et al., submitted) . As these compounds have already found a niche in the clinic, these mechanisms can be further explored with the ultimate goal of enhancing ON activity for therapeutic use.
